These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25523553)

  • 1. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis.
    Parkes M
    Dig Dis; 2012; 30(4):330-3. PubMed ID: 22796792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathogenesis of inflammatory bowel disease].
    Matricon J
    Med Sci (Paris); 2010 Apr; 26(4):405-10. PubMed ID: 20412746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetic markers in inflammatory bowel disease.
    Rodriguez-Bores L; Fonseca GC; Villeda MA; Yamamoto-Furusho JK
    World J Gastroenterol; 2007 Nov; 13(42):5560-70. PubMed ID: 17948929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2.
    Schwarz H; Posselt G; Wurm P; Ulbing M; Duschl A; Horejs-Hoeck J
    Immunobiology; 2013 Apr; 218(4):533-42. PubMed ID: 22795647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
    Abraham C; Cho JH
    Annu Rev Med; 2009; 60():97-110. PubMed ID: 18976050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedicine. Puzzling out the pains in the gut.
    Marx J
    Science; 2007 Jan; 315(5808):33-5. PubMed ID: 17204619
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.
    Cucchiara S; Stronati L; Aloi M
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of translational research in inflammatory bowel disease].
    Abreu MT; Sparrow MP
    Rev Gastroenterol Mex; 2007; 72(2):146-53. PubMed ID: 17966376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational research in inflammatory bowel disease.
    Abreu MT; Sparrow MP
    Mt Sinai J Med; 2006 Dec; 73(8):1067-73. PubMed ID: 17285196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between susceptibility and environment: examples from the digestive tract.
    Rogler G
    Dig Dis; 2011; 29(2):136-43. PubMed ID: 21734377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.